| Date Filed | Type | Description |
| 01/26/2023 |
4
| Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 213,000 options
@ $0.73, valued at
$155.5k
|
|
| 01/26/2023 |
4
| Warren Marshelle Smith (Chief Medical Officer) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 261,000 options
@ $0.73, valued at
$190.5k
|
|
| 01/26/2023 |
4
| Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 227,000 options
@ $0.73, valued at
$165.7k
|
|
| 01/26/2023 |
4
| First David (Chief People Officer) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 200,000 options
@ $0.73, valued at
$146k
|
|
| 01/26/2023 |
4
| BERNSTEIN HOWARD PHD MD (Interim Chief Executive Office) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 830,000 options
@ $0.73, valued at
$605.9k
|
|
| 08/16/2022 |
4
| Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Sold 1,183 shares
@ $3.3262, valued at
$3.9k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 1,183 shares
@ $2.703, valued at
$3.2k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Coulie Bernard (Director) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 20,000 options
@ $3.23, valued at
$64.6k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| First David (Chief People Officer) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 66,000 options
@ $6.57, valued at
$433.6k
|
|
| 02/15/2022 |
4
| Zajic Micah (Chief Business Officer) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 80,000 options
@ $6.57, valued at
$525.6k
|
|
| 02/15/2022 |
4
| Capasso Richard (See Remarks) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 42,000 options
@ $6.57, valued at
$275.9k
|
|
| 02/15/2022 |
4
| Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 395,000 options
@ $6.57, valued at
$2.6M
|
|
| 02/15/2022 |
4
| Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 97,000 options
@ $6.57, valued at
$637.3k
|
|
| 02/15/2022 |
4
| BERNSTEIN HOWARD PHD MD (Chief Scientific Officer) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 195,000 options
@ $6.57, valued at
$1.3M
|
|
| 01/13/2022 |
4
| Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Exercised 13,000 options
@ $1.81, valued at
$23.5k
|
|
| 01/04/2022 |
4
| Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 1,686 shares
@ $7.5905, valued at
$12.8k
|
|
| 01/04/2022 |
4
| Knopf Lawrence J (General Counsel) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Granted 454 shares
@ $7.5905, valued at
$3.4k
|
|
| 12/23/2021 |
4
| SCHULMAN AMY W (10% Owner) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Exercised 10,091 options
@ $2.02, valued at
$20.4k
Exercised 7,458 options
@ $4.59, valued at
$34.2k
Exercised 6,581 options
@ $4.59, valued at
$30.2k
|
|
| 12/22/2021 |
4
| Sharei Armon (President and CEO) has filed a Form 4 on SQZ Biotechnologies Co|
Txns:
| Exercised 11,049 options
@ $1.81, valued at
$20k
|
|
| 12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|